SH Imcyse Related Content
Diabetes – Is life without insulin possible?
Imagine a life without insulin: Research is bringing us closer to a cure and could change the lives of diabetes patients
Imcyse presents Imotopes™ – autoimmune disease treatment
ImotopesTM: a radically new approach to the treatment of autoimmune diseases – now entering Ph.2 testing in type 1 diabetes.
Embarking on a disruptive way to treat Multiple Sclerosis and other serious immune diseases
Isabelle Ote and Valérie Barette, Project Leaders at Belgian immunotherapy expert Imcyse, discuss its next phase of growth, and how to apply ImotopeTM technology to the treatment of MS.
Curative approach to severe autoimmune diseases
Andrew Mackie, VP Business Development tells us how Imcyse, a Belgian immunotherapy expert, seeks a curative approach to severe autoimmune diseases.
The beginning of the end for Type 1 diabetes: A new view from immunotherapy...
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces ImotopesTM a cutting-edge immunotherapy science with an excellent safety profile that could cure Type 1 diabetes or drastically change treatment options.
Rethinking Type 1 diabetes with a radically new immunotherapy approach
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces Imotopes™, the innovative new immunotherapy approach causing scientists to rethink Type 1 diabetes and its treatment.
